US biotech Celgene says that David Elkins has joined the company as executive vice president, chief financial officer.
Mr Elkins will join Celgene on July 1 and become CFO effective August 1. He will succeed current CFO Peter Kellogg, who will become Celgene’s EVP, chief corporate strategy officer until his retirement, planned for mid-2019.
Mr Elkins has more than 25 years of finance, strategy, operations, supply chain and business development experience in the USA, Europe and emerging markets. He joins Celgene from Johnson & Johnson, where he was worldwide vice president and CFO for Consumer Products, Medical Devices and corporate functions with $40 billion in revenue and a worldwide finance team of 1,800 employees.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze